Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 214

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 214
---
 out in the recitals; |

| (gg) | “Company Assets” means all of the assets (tangible and intangible), properties (real or                                                                                                                    
 personal) and equipment (including all attachments, accessories and all other items required for the operation thereof) owned, leased or otherwise used or held for use by the Company and its Subsidiary; |

| (hh) | “Company Outstanding Shares” means the total number of issued and outstanding Common Shares                                                                      
 at the Effective Time, on a partially diluted basis taking into account the Common Shares issuable upon exercise of all Options and upon settlement of all RSUs; |

| (jj) | “Consideration” means, per Common Share, the aggregate cash amount payable by the Company 
 pursuant to the Distribution plus one CVR issuable by the Purchaser;                      |

| (kk) | “Constating Documents” means notice of articles, articles of incorporation,                                                                                                          
 amalgamation, arrangement or continuation, as applicable, articles, by-laws, limited liability company operating agreement or other constating documents and all amendments thereto; |

| (ll) | “Contemplated Transactions” means (i) the Discontinuance; (ii) the Arrangement,                    
 and (iii) any other actions with respect to any other transactions contemplated by this Agreement; |

| (mm) | “Contract” means any agreement, indenture, contract, lease, deed of trust, license, option, 
 instrument, arrangement, undertaking or other commitment, whether written or oral;          |

| (nn) | “Convertible Securities” means, collectively, any agreement, option, warrant, right or other                                                                                                                                                              
 security or conversion privilege issued or granted by the Company that is exercisable or convertible into, or exchangeable for, or otherwise carries the right of the holder to purchase or otherwise acquire Common Shares, including pursuant to one or 
 more multiple exercises, conversions and/or exchanges;                                                                                                                                                                                                    |

| (oo) | “Court” means the Superior Court of Québec, Commercial Division; |

| (pp) | “CVR” means a contingent value right, which shall represent the right to receive potential                             
 payments, in cash, described in, and subject to and in accordance with the terms and conditions of, the CVR Agreement; |

| (qq) | “CVR Agreement” means the contingent value rights agreement to be entered on or prior to the                           
 Effective Time into by Parent, Purchaser and the Rights Agent in substantially the form attached